Here, 273 samples were leveraged, collected from uncomplicated malaria infections in Rukara, Rwanda during 2021 routine malaria programme clinical monitoring, to evaluate the status of molecular markers of anti-malarial resistance 3 years from the last measures as well as to assess for the presence of hrp2/3 gene deletions. The gene discussed is HDGFL2; the disease is malaria.